drugset / Trial / NCT01359228
Rifaximin Treatment of Papulopustular Rosacea
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine the effects of rifaximin on skin symptoms in patients with rosacea by double-blinded, placebo-controlled, crossover study.
Timeline
- Start
- 2013-04
- Primary completion
- 2014-06
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rifaximin | Other / unclassified | 550 mg | — |